Beating Coronavirus: India’s First Pharma Company BCPL Gets Clearance For Manufacturing Hydroxychloroquine Acharya Prafulla Chandra Ray.

Central Public Sector Undertaking Bengal Chemicals and Pharmaceuticals Limited (BCPL) on Friday (10 April) got clearance from drug control authorities to manufacture Hydroxychloroquine, which is being considered effective in treating Covid-19 patients.

The company got the licence days after the union government took the initiative for large-scale manufacture of the drug in view of the raging pandemic.

According to the company chairman P.M. Chandraiya, BCPL has the capability to churn out 10 lakh hydroxychloroquine tablets daily.

Founded in 1901, BCPL is the country's first pharmaceutical company, and once manufactured Hydroychloroquine. However, it stopped manufacturing the product decades back.

Chandraiya said the cost of raw materials for making the drug has gone up 20 times in the past few weeks.

"We have requested the union government to put a cap on the raw material prices," he said.

This news has been published via Syndicate feed. Only the headline has been changed.

An Appeal...

Dear Reader,

As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.

Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.

We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.

Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.

Become A Patron
Become A Subscriber
Advertisement